Sheets Smith Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sheets Smith Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,456	Closed	-$1.67M	–	223
2015 Q2	$1.67M	Sell	9,456 -9	-0.1%	-$1.62K	0.46%	67
2015 Q1	$1.64M	Sell	9,465 -208	-2%	-$35.7K	0.45%	65
2014 Q4	$1.58M	Sell	9,673 -40	-0.4%	-$6.64K	0.41%	70
2014 Q3	$1.56M	Buy	9,713 +1,134	+13%	+$174K	0.42%	70
2014 Q2	$1.26M	Buy	8,579 +1,069	+14%	+$148K	0.34%	82
2014 Q1	$1.04M	Buy	7,510 +565	+8%	+$85K	0.29%	98
2013 Q4	$879K	Buy	6,945 +440	+7%	+$45.5K	0.24%	107
2013 Q3	$598K	Buy	+6,505	New	+$525K	0.19%	149

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sheets Smith Wealth Management's JAZZ Position: Q3 2015 in Review

Sheets Smith Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 9,456 shares — an estimated $1.67M sold.

Sheets Smith Wealth Management first reported a position in JAZZ in Q3 2013 and held it in 8 quarters. The position peaked at $1.67M in Q2 2015. 362 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

Sheets Smith Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Sheets Smith Wealth Management sold 9,456 Jazz Pharmaceuticals shares in Q3 2015, an estimated $1.67M.
Sheets Smith Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 8 quarters.
Sheets Smith Wealth Management's Jazz Pharmaceuticals position peaked at $1.67M in Q2 2015.
362 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Sheets Smith Wealth Management's 13F filing for Q3 2015, filed 13 Nov 2015.